全球醫用同位素市場報告（2026 年）

近年來，醫用同位素市場規模顯著成長，預計將從2025年的72.6億美元成長到2026年的77.9億美元，複合年成長率（CAGR）為7.4%。過去幾年的成長可歸因於Technetium-99m在診斷領域的廣泛應用、醫院核子醫學科室的擴建、癌症診斷率的提高、對核子反應爐同位素供應的依賴以及醫學影像設備的進步。

預計未來幾年醫用同位素市場將穩定成長，到2030年市場規模將達到100.5億美元，複合年成長率（CAGR）為6.6%。預測期內的成長要素包括慢性病盛行率上升、標靶放射治療需求成長、迴旋加速器設施投資增加、個人化醫療發展以及同位素生產技術進步。預測期內的主要趨勢包括放射性同位素在診斷成像中的應用日益廣泛、核醫學療法的普及、精準腫瘤治療需求成長、基於迴旋加速器的同位素生產規模擴大以及對短壽命同位素供應鏈的日益重視。

癌症和心臟病發病率的上升預計將在未來推動醫用同位素市場的成長。癌症和心臟病發病率反映了這些疾病在特定時期內於人群中發生和持續的頻率，反映了更廣泛的公共衛生趨勢和預防策略的有效性。這些疾病發生率的上升趨勢與現代久坐的生活方式密切相關，而現代久坐的生活方式又源於科技產品的使用和文書工作的工作，導致人們的身體活動水平下降。醫用同位素在癌症和心臟病的診斷和治療中發揮重要作用，其應用包括正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT）等影像方法，以及放射療法和放射性支架等治療應用。例如，根據麥克米倫癌症援助組織的數據，截至2024年8月，英國有超過300萬人患有癌症，預計到2025年這一數字將達到350萬，到2030年將達到400萬，到2040年將達到530萬。因此，癌症和心臟病發病率的上升正在推動醫用同位素市場的成長。

醫用同位素市場的主要企業正致力於透過策略聯盟來增強其競爭優勢。策略聯盟是指組織之間為追求通用目標並實現互利共贏而建立的正式夥伴關係。例如，2023年9月，總部位於美國的醫療技術公司International Isotopes Inc.與總部位於美國的生物醫學設備製造商Phantech Medical達成合作，旨在為客戶提供整合解決方案。透過此次合作，兩家公司致力於設計、製造和銷售創新的密封同位素源，以支持醫學成像和治療診斷（治療診斷學）應用，從而改變臨床前成像領域的校準和參考源市場。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球醫用同位素市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧與自主智慧
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料和網路安全
  • 永續性、氣候技術和循環經濟
• 主要趨勢
  • 診斷影像中放射性同位素的使用日益增多
  • 擴大核醫學療法的應用
  • 精準腫瘤治療的需求日益成長
  • 利用迴旋加速器擴大同位素生產。
  • 日益關注短壽命同位素供應鏈

第5章 終端用戶產業市場分析

• 醫院
• 診斷影像中心
• 核子醫學診所
• 研究所
• 癌症治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球醫用同位素市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球醫用同位素市場規模、對比及成長率分析
• 全球醫用同位素市場表現：規模與成長，2020-2025年
• 全球醫用同位素市場預測：規模與成長，2025-2030年，2035年

第8章 全球潛在市場總量（TAM）

第9章 市場細分

• 依產品類型
• 診斷用放射性同位素、治療放射性同位素、治療及診斷用放射性同位素
• 透過製造方法
• 中子活化分析、迴旋加速器法、核子反應爐法及其他製造方法
• 透過使用
• 診斷影像、標靶放射性核種治療、近距離放射治療、放射性藥物研發
• 按最終用途
• 醫院、影像診斷中心、研究機構
• 按類型對診斷用放射性同位素進行細分
• Technetium-99m、氟-18、鎵-68、碘-123、碳-11和其他診斷用放射性同位素
• 治療性放射性同位素按類型細分
• 碘 131、鎦-177、釔 90、鍶 89、釤 153、錒 225 等治療放射性同位素
• 按類型對治療和診斷放射性同位素進行細分
• 鎵-68/鎦-177放射性同位素對、銅-64/銅-67放射性同位素對、碘-123/碘-131放射性同位素對、鈧-44/鈧-47放射性同位素對、鋱同位素對以及其他治療和診斷用放射性同位素

第10章 區域與國家分析

• 全球醫用同位素市場：依地區、績效及預測分類，2020-2025年、2025-2030年、2035年
• 全球醫用同位素市場：依國家、績效及預測分類，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 醫用同位素市場：競爭格局及市場佔有率（2024年）
• 醫用同位素市場：公司估值矩陣
• 醫用同位素市場：公司概況
  • Rosatom State Atomic Energy Corporation
  • Bayer AG
  • Siemens Healthineers AG
  • GE HealthCare
  • Urenco Ltd.

第37章：其他領先和創新企業

• Lantheus Holdings Inc.、Curium Pharma、Canadian Nuclear Laboratories、Eckert & Ziegler Strahlen-und Medizintechnik AG.、Advanced Accelerator Applications（諾華公司旗下）、Nordion Inc.、NTP Radioisotopes SOC Ltd.、放射性元素研究所 (IREIRE)、NorthStar移植(ITM)、EczacIbasI-Monrol Nuclear Products Co.、SHINE Medical Technologies LLC、Blue Earth Diagnostics Limited、Isologic Innovative Radiopharmaceuticals、IBA Radiopharma Solutions

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家及其策略

• 2030年醫用同位素市場：提供新機會的國家
• 2030年醫用同位素市場：充滿新機會的細分市場
• 2030年醫用同位素市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Medical isotopes are radioisotopes utilized in medicine, emitting positrons or gamma rays for diagnostic purposes. These isotopes aid in visualizing and targeting specific tissues or abnormalities within the body, facilitating tasks such as evaluating heart function, assessing blood flow to the heart muscle, and diagnosing coronary artery disease.

The main product types of medical isotopes comprise stable isotopes and radioisotopes. Stable isotopes are versions of chemical elements that do not decay over time, retaining their atomic structure indefinitely. Production methods for medical isotopes include neutron activation, cyclotrons, nuclear reactors, and others. These isotopes find applications in nuclear therapy, equipment radioactive sources, and diagnostic procedures. End users of medical isotopes include hospitals, diagnostic centers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the medical isotopes market by increasing costs related to imported nuclear materials, specialized equipment, and isotope processing components essential for medical applications. These impacts are most evident in diagnostic and therapeutic isotope supply chains across north america, europe, and asia pacific, where cross border movement of radioactive materials is tightly regulated. Higher costs and logistical delays have challenged timely isotope availability for hospitals and diagnostic centers. Conversely, tariffs have driven investments in domestic production facilities, cyclotron installations, and localized supply networks, improving long term supply security and healthcare resilience.

The medical isotopes market research report is one of a series of new reports from The Business Research Company that provides medical isotopes market statistics, including medical isotopes industry global market size, regional shares, competitors with a medical isotopes market share, detailed medical isotopes market segments, market trends and opportunities, and any further data you may need to thrive in the medical isotopes industry. This medical isotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical isotopes market size has grown strongly in recent years. It will grow from $7.26 billion in 2025 to $7.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to established use of technetium 99m in diagnostics, expansion of hospital nuclear medicine departments, growth in cancer diagnosis rates, reliance on nuclear reactors for isotope supply, advances in medical imaging equipment.

The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $10.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising demand for targeted radiotherapy, investment in cyclotron infrastructure, growth of personalized medicine, technological advancements in isotope production methods. Major trends in the forecast period include rising use of radioisotopes in diagnostic imaging, growing adoption of nuclear medicine therapies, increasing demand for precision oncology treatments, expansion of cyclotron based isotope production, higher focus on short lived isotope supply chains.

The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to how frequently these conditions occur and persist within a population over a given period, reflecting broader public health patterns and the effectiveness of prevention strategies. The increasing prevalence of these diseases is linked to modern sedentary lifestyles driven by technology use and desk-based occupations, which reduce physical activity levels. Medical isotopes play a critical role in diagnosing and treating cancer and heart disease through imaging modalities such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as in therapeutic applications including radiation therapy and radioactive stents. For instance, in August 2024, according to Macmillan Cancer Support, more than 3 million people in the UK were living with cancer, a number projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, rising cancer and heart disease rates are driving the growth of the medical isotope market.

Major companies in the medical isotope market are focusing on strategic collaborations to strengthen their competitive position. Strategic collaborations involve formal partnerships between organizations to pursue shared goals and deliver mutually beneficial outcomes. For example, in September 2023, International Isotopes Inc., a US-based medical technology company, partnered with Phantech Medical, a US-based biomedical hardware manufacturer, to integrate solutions for their customers. Through this collaboration, the companies aim to transform the calibration and reference sources market for pre-clinical imaging by designing, manufacturing, and distributing innovative sealed sources that support medical imaging and theranostics applications.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed amount. This acquisition provides Telix with enhanced access to ARTMS' cutting-edge radiopharmaceutical production technologies, strengthening its capabilities in developing and commercializing targeted radiopharmaceuticals for cancer imaging and therapy. ARTMS Inc. is a Canada-based medical equipment manufacturer specializing in technologies that improve the production of diagnostic imaging isotopes.

Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotop, Coqui RadioPharmaceuticals Corp., Jubilant DraxImage Inc.

North America was the largest region in the medical isotopes market in 2025. The regions covered in the medical isotopes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical isotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The medical isotopes market consists of sales of technetium-99m, carbon-11, and gallium-68 which serve specific purposes in medical diagnosis and therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Isotopes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical isotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical isotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical isotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Diagnostic Radioisotopes; Therapeutic Radioisotopes; Theranostic Radioisotopes
• 2) By Production Method: Neutron Activation; Cyclotron; Nuclear Reactor; Other Production Method
• 3) By Application: Diagnostic Imaging; Targeted Radionuclide Therapy; Brachytherapy; Radiopharmaceutical Research & Development
• 4) By End Use: Hospitals; Diagnostic Imaging Centers; Research Institutes
• Subsegments:
• 1) By Diagnostic Radioisotopes: Technetium-99m; Fluorine-18; Gallium-68; Iodine-123; Carbon-11; Other Diagnostic Radioisotopes
• 2) By Therapeutic Radioisotopes: Iodine-131; Lutetium-177; Yttrium-90; Strontium-89; Samarium-153; Actinium-225; Other Therapeutic Radioisotopes
• 3) By Theranostic Radioisotopes: Gallium-68 / Lutetium-177 Pairs; Copper-64 / Copper-67 Pairs; Iodine-123 / Iodine-131 Pairs; Scandium-44 / Scandium-47 Pairs; Terbium Isotope Pairs; Other Theranostic Radioisotopes
• Companies Mentioned: Rosatom State Atomic Energy Corporation; Bayer AG; Siemens Healthineers AG; GE HealthCare; Urenco Ltd.; Lantheus Holdings Inc.; Curium Pharma; Canadian Nuclear Laboratories; Eckert & Ziegler Strahlen- und Medizintechnik AG.; Advanced Accelerator Applications a Novartis company; Nordion Inc.; NTP Radioisotopes SOC Ltd.; The Institute for Radioelements (IRE); NorthStar Medical Radioisotopes LLC; Isotopen Technologien Munchen AG (ITM); EczacIbasI-Monrol Nuclear Products Co.; SHINE Medical Technologies LLC; Blue Earth Diagnostics Limited; Isologic Innovative Radiopharmaceuticals; IBA Radiopharma Solutions; Izotop; Coqui RadioPharmaceuticals Corp.; Jubilant DraxImage Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Medical Isotopes Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Medical Isotopes Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Medical Isotopes Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Medical Isotopes Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Use Of Radioisotopes In Diagnostic Imaging
  • 4.2.2 Growing Adoption Of Nuclear Medicine Therapies
  • 4.2.3 Increasing Demand For Precision Oncology Treatments
  • 4.2.4 Expansion Of Cyclotron Based Isotope Production
  • 4.2.5 Higher Focus On Short Lived Isotope Supply Chains

5. Medical Isotopes Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Imaging Centers
• 5.3 Nuclear Medicine Clinics
• 5.4 Research Institutes
• 5.5 Cancer Treatment Centers

6. Medical Isotopes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Isotopes Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Medical Isotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Medical Isotopes Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Medical Isotopes Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Medical Isotopes Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Isotopes Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Isotopes Market Segmentation

• 9.1. Global Medical Isotopes Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Radioisotopes, Therapeutic Radioisotopes, Theranostic Radioisotopes
• 9.2. Global Medical Isotopes Market, Segmentation By Production Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
• 9.3. Global Medical Isotopes Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Imaging, Targeted Radionuclide Therapy, Brachytherapy, Radiopharmaceutical Research & Development
• 9.4. Global Medical Isotopes Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Imaging Centers, Research Institutes
• 9.5. Global Medical Isotopes Market, Sub-Segmentation Of Diagnostic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Carbon-11, Other Diagnostic Radioisotopes
• 9.6. Global Medical Isotopes Market, Sub-Segmentation Of Therapeutic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Iodine-131, Lutetium-177, Yttrium-90, Strontium-89, Samarium-153, Actinium-225, Other Therapeutic Radioisotopes
• 9.7. Global Medical Isotopes Market, Sub-Segmentation Of Theranostic Radioisotopes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gallium-68 / Lutetium-177 Pairs, Copper-64 / Copper-67 Pairs, Iodine-123 / Iodine-131 Pairs, Scandium-44 / Scandium-47 Pairs, Terbium Isotope Pairs, Other Theranostic Radioisotopes

10. Medical Isotopes Market Regional And Country Analysis

• 10.1. Global Medical Isotopes Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Medical Isotopes Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Isotopes Market

• 11.1. Asia-Pacific Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Isotopes Market

• 12.1. China Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Isotopes Market

• 13.1. India Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Isotopes Market

• 14.1. Japan Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Isotopes Market

• 15.1. Australia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Isotopes Market

• 16.1. Indonesia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Isotopes Market

• 17.1. South Korea Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Isotopes Market

• 18.1. Taiwan Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Isotopes Market

• 19.1. South East Asia Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Isotopes Market

• 20.1. Western Europe Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Isotopes Market

• 21.1. UK Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Isotopes Market

• 22.1. Germany Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Isotopes Market

• 23.1. France Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Isotopes Market

• 24.1. Italy Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Isotopes Market

• 25.1. Spain Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Isotopes Market

• 26.1. Eastern Europe Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Isotopes Market

• 27.1. Russia Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Isotopes Market

• 28.1. North America Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Isotopes Market

• 29.1. USA Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Isotopes Market

• 30.1. Canada Medical Isotopes Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Isotopes Market

• 31.1. South America Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Isotopes Market

• 32.1. Brazil Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Isotopes Market

• 33.1. Middle East Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Isotopes Market

• 34.1. Africa Medical Isotopes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Medical Isotopes Market, Segmentation By Product Type, Segmentation By Production Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Isotopes Market Regulatory and Investment Landscape

36. Medical Isotopes Market Competitive Landscape And Company Profiles

• 36.1. Medical Isotopes Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Medical Isotopes Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Medical Isotopes Market Company Profiles
  • 36.3.1. Rosatom State Atomic Energy Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Urenco Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Medical Isotopes Market Other Major And Innovative Companies

• Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions

38. Global Medical Isotopes Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Isotopes Market

40. Medical Isotopes Market High Potential Countries, Segments and Strategies

• 40.1 Medical Isotopes Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Medical Isotopes Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Medical Isotopes Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer